Drug Index

COSENTYX

Generic: SECUKINUMAB

Review priority: STANDARD Marketing status: Prescription

Route: INJECTION
Class: General Medications
Safety profile: routine
Latest regulatory update: 12 Mar 2026, 12:00 am (UTC)

Structured Monograph

Approval overview COSENTYX is listed in Drugs@FDA under application 125504 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient SECUKINUMAB Form and strength INJECTABLE;INJECTION - 150MG/ML Sponsor NOVARTIS PHARMS CORP Submission history Latest submission status date: 2026-03-12 00:00:00. Submission type: SUPPL.